Vitaspring Biomedical annual current ratio
2017
2018
2021
2022
2023
2024
2025
2026
Vitaspring Biomedical Current Ratio Growth & History (VSBC)
Vitaspring Biomedical's current ratio was 0.00 for fiscal 2026.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | 0.00 | 0.00 | +3408.32% |
| 2025 | 2025-01-31 | 0.00 | −0.01 | −99.00% |
| 2024 | 2024-01-31 | 0.01 | −0.14 | −95.24% |
| 2023 | 2023-01-31 | 0.14 | −1.62 | −91.92% |
| 2022 | 2022-01-31 | 1.76 | −0.27 | −13.46% |
| 2021 | 2021-01-31 | 2.04 | — | — |
| 2018 | 2018-01-31 | 0.68 | −2.17 | −76.27% |
| 2017 | 2017-01-31 | 2.85 | — | — |
Vitaspring Biomedical quarterly current ratio
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | 0.00 | 0.00 | +2911.78% |
| Q4 2026 | 2026-01-31 | 0.00 | 0.00 | +3408.32% |
| Q3 2026 | 2025-10-31 | 0.00 | — | — |
| Q2 2026 | 2025-07-31 | 0.00 | — | — |
| Q1 2026 | 2025-04-30 | 0.00 | — | — |
| Q4 2025 | 2025-01-31 | 0.00 | — | — |
| Q4 2023 | 2023-01-31 | 0.14 | −1.62 | −91.92% |
| Q3 2023 | 2022-10-31 | 4.33 | 2.41 | +126.01% |
| Q2 2023 | 2022-07-31 | 4.23 | −2.47 | −36.87% |
| Q1 2023 | 2022-04-30 | 5.78 | 1.45 | +33.60% |
| Q4 2022 | 2022-01-31 | 1.76 | −0.27 | −13.46% |
| Q3 2022 | 2021-10-31 | 1.92 | 1.91 | +21044.15% |
| Q2 2022 | 2021-07-31 | 6.70 | 6.69 | +128095.01% |
| Q1 2022 | 2021-04-30 | 4.33 | 4.28 | +8935.58% |
| Q4 2021 | 2021-01-31 | 2.04 | — | — |
| Q3 2021 | 2020-10-31 | 0.01 | — | — |
| Q2 2021 | 2020-07-31 | 0.01 | — | — |
| Q1 2021 | 2020-04-30 | 0.05 | — | — |
| Q1 2019 | 2018-04-30 | 1.10 | 0.13 | +13.39% |
| Q4 2018 | 2018-01-31 | 0.68 | −2.17 | −76.27% |
| Q3 2018 | 2017-10-31 | 0.81 | — | — |
| Q2 2018 | 2017-07-31 | 0.84 | — | — |
| Q1 2018 | 2017-04-30 | 0.97 | — | — |
| Q4 2017 | 2017-01-31 | 2.85 | — | — |
Vitaspring Biomedical current ratio trends
Over the last five fiscal years, Vitaspring Biomedical's current ratio decreased from 2.04 to 0.00, a change of −2.03. The latest reported quarter, Q1 2027, shows 0.00.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical source filings ↗